Carlo Signorelli
Overview
Explore the profile of Carlo Signorelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
252
Citations
3276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nelli F, Ruggeri E, Virtuoso A, Giannarelli D, Raso A, Natoni F, et al.
Explor Target Antitumor Ther
. 2025 Mar;
6:1002287.
PMID: 40061137
Aim: The interaction of concomitant benzodiazepine (BZD) exposure during immune checkpoint blockade has not been comprehensively investigated to date. This research aimed to determine the influence of BZD intake on...
2.
Pennisi F, Pinto A, Ricciardi G, Signorelli C, Gianfredi V
Antibiotics (Basel)
. 2025 Feb;
14(2).
PMID: 40001378
Antimicrobial resistance (AMR) poses a critical global health threat, necessitating innovative approaches in antimicrobial stewardship (AMS). Artificial intelligence (AI) and machine learning (ML) have emerged as transformative tools in this...
3.
Correia T, Pereira A, Barros H, Davidovitch N, Leighton L, McCallum A, et al.
Public Health Rev
. 2025 Feb;
46:1608208.
PMID: 39926053
No abstract available.
4.
Lucchetti J, Angotti L, Parisi A, Basso M, Polito M, Zoratto F, et al.
Clin Colorectal Cancer
. 2025 Jan;
PMID: 39856001
Background: Both aflibercept and bevacizumab-based regimens are available II-line treatment options for patients with metastatic colorectal cancer (mCRC). However, no head-to-head trials established the optimal anti-angiogenic strategy for this setting....
5.
Pennisi F, DAmelio A, Cuciniello R, Borlini S, Mirzaian L, Ricciardi G, et al.
Vaccines (Basel)
. 2025 Jan;
13(1).
PMID: 39852816
Background/objectives: Vaccines have been recognized as one of the most effective public health interventions. However, vaccine-associated anaphylaxis, although rare, is a serious adverse reaction. The incidence of anaphylaxis related to...
6.
Signorelli C, Pennisi F, DAmelio A, Conversano M, Cinquetti S, Blandi L, et al.
Vaccines (Basel)
. 2025 Jan;
13(1).
PMID: 39852795
Background: The success of vaccination programs depends on a complex interplay of logistical, social, and structural factors. The objective of this study was to analyze the different approaches to vaccine...
7.
Pennisi F, Gentile L, Borlini S, Gianfredi V, Signorelli C
Ann Ig
. 2025 Jan;
PMID: 39811964
Background: Glaucoma, diabetic retinopathy, and age-related macular degeneration impose substantial economic burdens on healthcare systems due to their high prevalence and chronic nature. Nevertheless, comprehensive Italian data is limited. This...
8.
Pennisi F, Pinto A, Ricciardi G, Signorelli C, Gianfredi V
Eur J Clin Microbiol Infect Dis
. 2025 Jan;
44(3):463-513.
PMID: 39757287
The increasing threat of antimicrobial resistance has prompted a need for more effective antimicrobial stewardship programs (AMS). Artificial intelligence (AI) and machine learning (ML) tools have emerged as potential solutions...
9.
Signorelli C, Calegari M, Anghelone A, Passardi A, Frassineti G, Bittoni A, et al.
Curr Oncol
. 2024 Dec;
31(12):7793-7808.
PMID: 39727697
Background: There is ongoing discussion around the optimal course of treatment for metastatic colorectal cancer (mCRC) following the second line. Trifluridine/tipiracil (T) and regorafenib (R) have been the mainstay of...
10.
Signorelli C, Oleari F, Greco D, Ruocco G, Guerra R, Rezza G, et al.
Ann Ist Super Sanita
. 2024 Dec;
60(4):247-251.
PMID: 39699977
Five consecutive national vaccination plans (from 1999 to 2025) were revised, outlining their objectives, challenges, and results. Vaccination coverage for children consistently approached target levels, though regional differences emerged. In...